NIH AI Restriction
NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyDevelopment, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21)
About This Grant
-The National Cancer Institute (NCI) has identified risk prediction as an area of extraordinary opportunity in NCI s 2006 Plan and Budget Proposal: The Nation's Investment in Cancer Research (http://plan2006.cancer.gov/). To explore this opportunity, the NCI Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Treatment and Diagnosis (DCTD) solicit applications for research projects to develop, apply, and evaluate new and existing cancer risk and prognostic prediction models for use by researchers, clinicians, and the general public. -The purpose of this Funding Opportunity Announcement (FOA) is to encourage clinicians, epidemiologists, geneticists, statisticians, and translational researchers working in the field of cancer control and prevention to improve existing models for cancer risk and prognosis by developing innovative research projects that use existing data; develop new models for cancer risk and prognosis; and validate new models and evaluate their utility in research and clinic settings. Applications that are focused on the identification and characterization of prognostic/diagnostic markers are NOT responsive to this FOA. -This FOA is designed to provide a mechanism of support for investigators to address two major challenges in model development, which are: integrating diverse types of data (e.g., clinical, demographic, pathologic, environmental, epidemiologic, outcomes, and genetic data from varied data marts or warehouses); and ensuring adequate validation (i.e., using multiple separate populations to define sensitivity, specificity, and positive and negative predictive values).
Grant Summary
Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) is a National Institutes of Health grant providing funding that varies by award for university. Applications are accepted on a rolling basis. Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $0K
Rolling / Open
- 1Confirm your organization is eligible for Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) from National Institutes of Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.
Don't want to draft it yourself?
We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21): Frequently Asked Questions
Who is eligible for the Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21)?
Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) is offered by National Institutes of Health and is generally open to university. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) provide?
Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) provides an amount that varies by award per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) deadline?
Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) accepts applications on a rolling or ongoing basis, so there is no single fixed deadline. Confirm current timing with the funder, National Institutes of Health, before you apply, and submit as early as possible because rolling programs can close once funds are committed.
How do you apply for the Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21)?
To apply for Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.